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The contact-dependent intrinsic pathway of fibrinolysis involving factor XII, prekallikrein (PK) and pro-urokinase (pro-UK) remains poorly 
understood. Casein autography of washed, intact platelets revealed both PK and pro-UK. Accordingly, platelets may mediate physiological 
thrombolysis by this pathway since factor XIIa activates PK and kallikrein activates pro-UK. Acid washing dissociated PK but not pro-UK from 
platelets. Exogenous pro-UK was specifically incorporated by platelets from the ambient fluid and similarly could not be dissociated from intact 
platelets. Therefore, platelets may also mediate an effect from therapeutically administered pro-UK by prolonging its half-life. 
Pro-urokinase: Prekallikrein; Platelet; Fibrinolysis 
1. INTRODUCTION 
Pro-urokinase (pro-UK) is a plasminogen proactiva- 
tor which is activated to urokinase (UK) by both plas- 
min [l] and kallikrein [2]. Factor XIIa activates plasma 
prekallikrein (PK) [3], and initiates the contact pathway 
of blood coagulation which has also long been impli- 
cated in fibrinolysis (see review by Kluft et al. [4]). This 
so-called ‘intrinsic pathway’ of fibrinolysis, to which 
pro-UK also belongs [5,6], remains poorly character- 
ized and no mechanism by which it targets fibrin clots 
has been identified. 
Although exogenous pro-UK induces fibrin-specific 
clot lysis in plasma in vitro and in vivo [ 11, the biological 
role of endogenous pro-UK is believed to be restricted 
to tissue remodeling, inflammation and cell migration 
[7-91 rather than fibrinolysis. Studies with inhibiting 
antibodies to urokinase-type plasminogen activator (u- 
PA) have failed to show any effect on spontaneous lysis 
of fibrin clots in plasma, which was found to be due 
exclusively to tissue plasminogen activator (t-PA) 
[ 10,111. Furthermore, the normal plasma concentration 
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of pro-UK is less than 2 r&ml [ 121 and it does not bind 
to fibrin [13]. 
These studies of pro-UK-mediated fibrinolysis, and 
most others in the literature, were conducted in platelet- 
free systems. By contrast, when clots were made up 
from platelet-rich instead of platelet-poor plasma, a sig- 
nificant fibrinolytic effect by endogenous pro-UK was 
identified [l 11. We have also previously shown that plate- 
let-rich clots were lysed almost twice as rapidly by ex- 
ogenous pro-UK as platelet-poor clots, whereas the re- 
verse was the case with t-PA under these conditions [14]. 
The initial purpose of the present study was to investi- 
gate the interaction of pro-UK and platelets in order to 
help explain these observations. The findings indicated 
that PK/kallikrein binds to platelets providing a mecha- 
nism for the promotion of pro-UK activation by plate- 
let-rich clots. Additionally, it was shown that a portion 
of pro-UK in blood is found in platelets and that plate- 
lets take up exogenous pro-UK from the ambient fluid. 
2. MATERIALS AND METHODS 
Native pro-UK purified from the culture medium of a human kid- 
ney tumor cell was obtained from Collaborative Research Inc. 
(Bedford, MA). Recombinant pro-UK from E. coli was obtained from 
Farmitaha Carlo Erba (Milan, Italy). Low molecular weight (LMW) 
UK was obtained from Abbott Laboratories (Chicago, IL). Plasma 
prekallikrein (PK) was obtained from Enzyme Research Laboratory 
(South Bend, IN) and a polyclonal antibody to PK was obtained from 
Calbiochem (San Diego, CA). Plasma PK activator (PPA), containing 
factor XII, ellagic acid, cephalin and HMW kininogen, was obtained 
from Kabi Pharmacia Hepar (Franklin, OH). Bdellin was purchased 
from Biopharm (Charleston, SC) and soybean trypsin inhibitor from 
Sigma (St. Louis, MO). 
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Human platelets were prepared from venous blood collected into 
3.8% citrate (9:l). Platelet-rich plasma (PRP) was obtained by centrif- 
ugation at 160 x g for 15 min at room temperature. After the addition 
of prostaglandin E, (PGE,) (1 PM), the PRP was centrifuged at 
725 xg and the platelet-poor plasma (PPP) removed. The platelets 
were resuspended by gentle mixmg in HEPES Tyrodes-albumin buffer 
(HTA) containing 128 mM NaCI, 8.9 mM NaHCO,, 5.6 mM dextrose, 
10 mM HEPES, 0.35 mg/ml BSA, 12 mM KCl, 3 mM KHZPO,, 3 mM 
MgCl,, pH 7.5. The washing was repeated twice and the supernatant 
removed after centrifugation each time. Platelet counts were deter- 
mined in a Coulter counter (Coulter Electronics, Hialeah, FL). 
2.3. Incubation ofplatelets wrth pro-UK. UK or t-PA 
Acid washing of platelets was carried out as follows: A pellet of 
= 1 x 10’ washed platelets was resuspended in 1 .O ml of 20 mM citrate 
(pH 4.5.0.15 M NaCl, 0.3 mg/ml BSA. After 5 min, the platelets were 
spun down and resuspended in 10 ml of HTA buffer. After 5 mm, the 
pfatelet pellet was recovered by centrifugation and then analyzed by 
zymography. Acid washing by thts procedure was shown to com- 
pletety remove platelet-bound PK and t-PA. 
In order to determine if pro-UK was taken up by platelets, washed 
platelets were incubated (37°C) in PPP or HTA buffer (- 4 x10* 
platelets/ml) enriched with 0.5&ml of native or ret-pro-UK, HMW- 
UK, LMW-UK. or t-PA for 5 min. The two UK preparations and 
t-PA were incubated only in buffer to avoid complexation with inhib- 
itors. Thereafter, the platelets were recovered by centrifugation 
(725 xg for 15 mm), washed two ttmes in HTA buffer and then 
resuspended in bank plasma and reincubated for 0.5, 1, 2 and 22 h. 
At the end of the final incubation period, the platelets were recovered 
by centrifugation, washed two times in HTA buffer and examined by 
zymography on plasminogen enriched casem plates. The correspond- 
ing PPP (20 ~1) at the end of each incubation period was examined 
alongside the platelets. 
3. RESULTS 
More than 20 preparations from 10 different donors were analyzed. 3.1. The endogenous u-PA intrinsic to platelets and 
plasma (Fig. 1) 
2.1. Sodium dodecyl sulfate polyacrylamide gel electrophoresis ( SQS- 
PAGE) and casein autography (qnography) 
Samples were electrophoresed at 15 mA constant current m 7.5% 
polyacrylamidc slab gels using the buffer system of Laemmh (15). 
Zymographic analysis was performed according to the method of 
Grancill-porno and Reich 1161 modified by Vassalli et al. [I 71. After 
eiectrophoresis, the acrytamide slabs were washed by agitation for 2 
h in 2.5% Triton X-100 in water, followed by 1 h in 0.1 Tris-HCl (pH 
S.O), layered over an underlay consrstmg of 0.8% agarose (Agarose low 
melting, Fisher Biotech), casein (2% w/v; Carnation Non-fat Dry 
Milk) and plasmmogen (2040~glml) in 0.1 M Tris-HCl (pH 8.0) and 
incubated at 37°C for = 20 h. 
For most studies of PK, plasminogen-free plates were used. This 
made it possible to incubate (37°C) the casein plate for at least four 
days, required to visuahze PK. without degradation of the casein. 
Since PK comigrates with plasmlnogen in SDS-PAGE, we found that 
it is readily visualized on a piasmmogen-free plate by addmg plasmin- 
ogen (4 &ml) directly to the sample. 
A representative zymogram of platelets (1 x 108) 
washed only once showed a dominant plasminogen acti- 
vator band of activity at -‘I 53 kDa corresponding to 
u-PA. In addition, a band at = 70 kDa could be seen 
consistent with t-PA, which has previously been shown 
to bind to platelets by a specific, low affinity binding site 
[ 181. In addition, a = 100 kDa band was seen in the 
platelets, consistent with a UICplasminogen activator 
inhibitor-l (PAI-1) complex (lane 1). The correspond- 
ing PPP also showed a band of u-PA activity and a 
= 120 kDa band consistent with a t-PA:PAI-1 complex. 
The UK:PAI-1 complex was invariably absent in the 
PPP (lane 2). From other zymograms (not shown) of 
Sample preparations. The washed platelet pellet was dissolved m 
SDS sample buffer (50 ~1) for electrophoresis. To determine if activi- 
ties in the preparations were associated specifically with the platelets. 
20 ~1 of the final wash was analyzed for comparison wtth the platelet 
pellet which was < 4,ul in volume. All samples were boiled in SDS for 
1 mm 
I 2 
kDo 
2.2. Platelet-associated ka~iikrein ucttvity and pro-UK acttvatmg 
Amidolytic activity. Washed platelets in HTA buffer were incubated 
with 8 pi/ml of PPA for 30 min to activate PK. The assay mixture (100 
~1) contained platelets (1 x lO*/ml) and kallikrein synthetic substrate. 
S-2302 (0.4 mM) in HTA buffer. The converston of S-2302 was deter- 
mined using a microtiter plate reader (Dynatech MR 5000, Dynatech 
Laboratories, Inc., Chantilly, VA). From the absorbance change at 
410/490 nm, the concentration of kallik~in present in the sample was 
calculated using a calibratron curve made under the same conditions 
with known concentrations of kallikrein. The concentratron of active 
platelet-bound kallikrein was measured as the soybean trypsin-mhib- 
rtable (SBTI) activity against S-2302 in separate mcubattons. 
d-/O 
Pro- UK activating activity. Activatron mixtures (100 ~1) were made 
directly in the microttter plate and contamed 1 x 10’ platelets/ml in
HTA buffer with a range of concentration of pro-UK (20-800 nM) 
in the presence of 0.6 mM substrate for urokinase (S-2444) at room 
temperature. The generation of S-2444 activity before and after the 
addition of PPA to activate PK was measured continuously at 410 nm 
(agamst a reference wavelength of 490 nm) on a mrcrotiter plate 
reader. The effects of PPA and pro-UK alone or m combination on 
the substrate were tested. 
Fig. 1. Zymography (plasminogen-en~ched casein) of washed platelets 
(1 x 10’) and PPP (20 ~1). Lane 1: platelets washed once in HTA 
buffer; 2: correspondmg PPP; 3: platelets preincubated with native 
pro-UK (0.5 pg/ml) m PPP for 5 min before washing twice in HTA 
buffer; 4, the same platelets after acid washing. 
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PPP (l-20 ~1) and platelets (107-lo*), it was estimated 
When platelets were washed twice, the t-PA band 
that = 20% of the u-PA in blood was present in platelets 
based on their zymographic activities. The final wash 
could no longer be seen (lane 3). Subsequent acid wash- 
(20 ~1 HTA buffer) was invariably devoid of activity, 
indicating that the buffer remaining with the platelet 
ing of the platelets induced only slight reduction in the 
pellet was not the source of the activities seen. 
intensity of the u-PA or u-PA:PAI-1 complex (lane 4). 
The increased density of the bands in lanes 3 and 4 was 
due to additional pro-UK in the platelets as a result of 
preincubation (5 min at 37°C) in PPP enriched with 
pro-UK (0.5 pg./ml). 
3.2. Platelet-associated PK and PK in plasma (Fig. 2) 
A Comassie stain of prekallikrein and plasminogen 
showed that they migrated in similar positions on SDS- 
PAGE (A). This made it possible to add plasminogen 
to the PK-containing sample and perform zymography 
on a plasminogen-free plate to overcome the problem 
of casein disintegration by plasmin over the lengthy 
period of incubation needed to visualize the PK. 
On a plasminogen-free casein plate (incubated 4 
days), a band consistent with PK was the only activator 
visualized in plasma under these conditions. Prekal- 
likrein (50 pg/ml) in the absence of plasminogen in the 
loaded sample induced no lysis (not shown). Plasmino- 
gen (4 pg/ml) alone induced essentially no lysis. How- 
ever, PK together with plasminogen in the sample in- 
duced a lysis band comparable in position to the single 
lysis band seen in plasma (B). Similarly, platelets alone 
induced no lysis on the plasminogen-free plate whereas 
platelets plus plasminogen induced a lysis band compa- 
rable to that induced by plasma and by PK plus plas- 
minogen (C). 
The immunoreactivity of the = 90 kDa lysis band in 
plasma and platelets was determined by showing that 
when PK antibody was included in the sample, lysis was 
inhibited. This was also previously observed by Tsuda 
et al. [6] for the band in this position in normal plasma. 
The platelet-associated activity was similarly inhibited. 
3.3. Platelet ka~likrein and pro- UK activating activities 
Further ~onfi~ation that this activity was PK was 
obtained by activating the platelet preparations with 
PPA in the presence of kallikrein substrate (S-2302). An 
activity corresponding to 40-200 pM kallikrein per 
1 x lo8 platelets was found. In the absence of platelets 
or PPA, no significant substrate activation was induced. 
No amidolytic activity against UK substrate (S-2444) 
Pro-UK activating activity was assayed with a reac- 
tion mixture of platelets, pro-UK (400 nM) and UK 
was detectable in these preparations. 
synthetic substrate (S-2444) activated with PPA. Uroki- 
nase generation occurred as measured by activation of 
the substrate, which could be inhibited by the addition 
of soybean trypsin inhibitor to inhibit kallikrein, but 
not by Bdellin (a specific inhibitor of plasmin). In the 
absence of platelets, no significant activation of the sub- 
strate occurred under these conditions. 
3.4. Uptake of pro-UK and ret-pro-UK by platelets 
When platelets were incubated for 5 min in plasma 
enriched with 0.5 &ml pro-UK, there was significant 
uptake of pro-UK by the platelets as indicated by zy- 
mography. This pro-UK was not significantly dissoci- 
ated by acid washing as previously shown (Fig. 1). 
The uptake of pro-UK from the ambient fluid was 
most apparent when ret-pro-UK was used, since due to 
the absence of carbohydrate, it was clearly resolved 
migrating ahead of the endogenous pro-UK (Fig. 3). 
The control platelet preparation is shown (lane 2) 
alongside the PPP (lane 3). The latter induced no lysis 
bands due to the relatively short (14 h) incubation time 
of the plate. The higher MW lysis zone from the en- 
A B C 
kDa 
Fig. 2. SDS-PAGE Comassie stained (A) and zymograms on plasminogen-free casein (B and C). Al: MW standards; A2: PK; A3: plasminogen. 
Bl : MW standards; B2: PPP (20 ~1); B3: plasminogen (4 &ml); B4: PK (50 &ml) + plasminogen. C 1: MW standards; C2: PK + plasminogen; 
C3: platelets (I x IO’); C4: platelets + plasminogen. 
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dogenous pro-UK intrinsic to platelets was similar in all 
the lanes indicating no significant differences in the 
number of platelets in each sample and that the en- 
dogenous pro-UK in platelets was not dissociated by 
the incubations in PPP for up to 22 h. The platelets 
incubated with ret-pro-UK and then washed and rein- 
cubated in normal, unenriched PPP for 30 min (lane 4) 
1 h (lane 5) 2 h (lane 6) and 22 h (lane 9) induced 
comparable lysis zones, indicating no apparent dissocia- 
tion of the ret-pro-UK over this period of time. A small 
but unchanging amount of ret-u-PA activity was seen 
in the corresponding PPP at the end of each incubation 
period (lanes 6, 8 and 10) indicating that a fraction of 
the ret-pro-UK was released within the first 30 min, 
probably representing the unincorporated portion re- 
maining on the receptor. However, the bulk of the plate- 
let-associated ret-pro-UK remained unaffected by the 
incubation, consistent with it having been incorporated. 
Moreover, this portion of the ret-pro-UK also resisted 
dissociation by acid washing as shown for native pro- 
UK in Fig. 1. A very faint lysis zone migrating at = 100 
kDa, consistent with a UK:PAI-1 complex was seen in 
the platelet preparations (lanes 2, 4, 5, 7 and 9) but not 
in the PPP suggesting that this complex was also inside 
the platelets (Fig. 3). 
Incubation of platelets with native HMW-UK in 
HTA buffer induced similar uptake of the UK. Uptake 
of UK was not accompanied by any more inhibitor 
complex formation than that seen with pro-UK, sug- 
gesting that storage of u-PA in platelets is separate from 
that of PAI- or that most of the latter is in a latent 
form. By contrast, incubation with LMW-UK or t-PA 
in HTA buffer at the same concentrations induced no 
uptake by platelets (data not shown), indicating that the 
specificity of uptake was comparable to that of the 
platelet u-PA receptor described by Vaughan et al. [19]. 
4. DISCUSSION 
The present study showing that PK/kallikrein is asso- 
ciated with platelets is based on molecular weight, char- 
acteristic response when loaded with plasminogen on a 
plasminogen-free casein plate, immuno and substrate 
reactivities and pro-UK activating activity. Since pro- 
UK activation is importantly involved in its fibrinolytic 
effect, the findings may explain the observation that 
platelets promote fibrinolysis by both endogenous [ll] 
and exogenous [14] pro-UK. 
The finding that pro-UK is also associated with plate- 
lets, localizes two proenzymes of the intrinsic fibri- 
nolytic pathway to a thrombus, where factor XIIa can 
initiate a sequence of reactions resulting in focal plas- 
min generation by directly activating PK to kallikrein 
which in turn activates pro-UK to UK. A relationship 
between factor XII and fibrinolysis has been suspected 
for more than 30 years since the observations of Niewia- 
rowski and Prou-Wartelle [20] and was recently further 
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Fig. 3. Zymogram (plasminogen-enriched casein) of washed platelets 
(1 x10*) (lane 1); PPP (2); platelets preincubated (37°C for 5 mm) in 
HTA buffer enriched with ret-pro-UK (0.5 &ml), then washed and 
incubated in normal PPP for 30 min [4]; 1 h [S]; 2 h [7] and 22 h [9]. 
The corresponding PPP’s at the end of each mcubatton period are 
shown in lanes 6. 8 and 10. 
characterized by Binnema et al. [21]. The extensive lab- 
oratory data in the literature on this fibrinolytic path- 
way is supported by the clinical observations that factor 
XII deficient patients, notably the index case John 
Hageman [22], rather than having a bleeding diathesis 
appeared to be predisposed to both venous thromboem- 
bolism [23] and acute coronary thrombosis [24]. How- 
ever, a mechanism by which the contact dependent in- 
trinsic pathway mediates fibrinolysis has not previously 
been proposed. 
The present finding of platelet-associated pro-UK ex- 
tends two previous observations. Park et al. found pro- 
UK associated with sonicated platelet membrane and 
concluded that it was located in the outer leaflet but no 
role for it was defined [25]. Vaughan et al. identified the 
presence of a u-PA receptor on platelets which was, 
however, of low affinity (- 130 nM) and therefore con- 
sidered to be of uncertain physiological relevance [19]. 
The specificity of this receptor, which did not bind t-PA 
or LMW-UK, was similar to the specificity of platelet 
uptake observed in the present study. Both endogenous 
pro-UK, intrinsic to platelets, and exogenous pro-UK 
were incorporated by platelets, as evidenced by a resis- 
tance to dissociation by acid washing or by prolonged 
(22 h) incubation in a pro-UK-poor environment. Since 
neither LMW-UK nor t-PA were similarly incorpo- 
rated, it is postulated that the platelet u-PA receptor 
identified by Vaughan et al. [19] may serve the function 
of endocytosis. However, studies to determine the loca- 
tion of the pro-UK in platelets remain to be done. It was 
estimated that platelets contain about 20% of the pro- 
UK present in the blood of healthy subjects. 
The incorporation of exogenous native pro-UK and 
non-glycosylated ret-pro-UK from the ambient plasma 
into platelets may explain certain intriguing clinical 
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findings. For example, it has been reported in patients 
with acute coronary thrombosis, that pro-UK admini- 
stration is associated with an exceptionally low reocclu- 
sion rate [26], which in one study was under 2% 1271 as 
compared with about 20% for t-PA [28] and about 10% 
for streptokinase [29]. This low reocclusion rate sug- 
gests that pro-UK may have a prolonged post-infusion 
effect which cannot be explained by its very short (- 7 
min) plasma half-life. Additionally, it has been reported 
that administration of pro-UK as a single intravenous 
bolus injection in dogs, an animal in which the tin of 
pro-UK is equally short [l], induced an unexpected pro- 
longed (> 40 min) thrombolytic effect [30]. These obser- 
vations could be explained by the present study which 
suggests that a portion of infused pro-UK may be rap- 
idly incorporated by platelets thereby giving it a long 
half-life and a potentially useful location for a targeted 
thrombolytic and antithrombotic effect. 
In contrast to pro-UK, the platelet-ass~iated PK 
was dissociated by extensive washing in HTA buffer or 
by acid washing, consistent with it binding to a surface 
protein. To our knowledge, PK has not previously been 
reported to be associated with platelets. However, a 
specific binding site on intact platelets for high molecu- 
lar weight kininogen [31], which also protects it from 
degradation by kallikrein 2321, has been identified. Since 
PK binds tightly to high molecular weight kininogen 
[33] and is present in plasma at a relatively high concen- 
tration (= 40 yglml) [33], the present finding of platelet- 
associated PK is not surprising. The postulated sig- 
nificance to intrinsic fibrinolysis of this co-localization 
of PK and pro-UK by platelets is that it provides a 
mechanism by which factor XII may trigger thrombus- 
dependent and targeted plasminogen activation. To 
date, almost all studies of this pathway have been con- 
fined to platelet-free systems which may explain why it 
has defied delineation. 
In conclusion, evidence is presented which indicates 
that a portion (- 20%) of the pro-UK intrinsic to blood 
is found inside platelets, and that exogenous pro-UK in 
plasma is rapidly incorporated by platelets. Since t-PA 
and LMW-UK were not incorporated, this profile is 
consistent with a previously identified platelet u-PA re- 
ceptor [19], which is, therefore, implicated in endocyto- 
sis. Prekallikrein was found associated with the surface 
of intact platelets. This co-localization of these two zy- 
mogens prompts the postulation that the contact de- 
pendent, intrinsic pathway of fibrinolysis is mediated by 
platelets at the site of a forming thrombus where factor 
XIIa can initiate the sequence of reactions leading to 
plasmin generation. In addition, the rapid incorpora- 
tion of exogenous pro-UK from plasma into platelets 
may be of significance to the use of pro-UK in therapeu- 
tic thrombolysis. 
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